Table 5.
Covariate: Pathology Diagnosis | Full Sample (n = 229) | Single Definitive Diagnosis (n = 191) | Favored Diagnosis (n = 38) | P-Value* |
---|---|---|---|---|
Ductal Papilloma | 3 (1%) | 3 (2%) | 0 (0%) | 1 |
Cystadenoma | 16 (7%) | 12 (6%) | 4 (11%) | 0.31 |
Canalicular Adenoma | 16 (7%) | 13 (7%) | 3 (8%) | 0.73 |
Sialadenoma Papilliferum | 6 (3%) | 6 (3%) | 0 (0%) | 0.59 |
Pleomorphic Adenoma / Myoepithelioma | 99 (43%) | 86 (45%) | 13 (34%) | 0.28 |
Basal Cell Adenoma | 2 (1%) | 0 (0%) | 2 (5%) | 0.027 |
Oncocytoma | 1 (0%) | 1 (1%) | 0 (0%) | 1 |
Mucoepidermoid Carcinoma | 42 (18%) | 40 (21%) | 2 (5%) | 0.021 |
Polymorphous Adenocarcinoma | 20 (9%) | 15 (8%) | 5 (13%) | 0.34 |
Adenoid Cystic Carcinoma | 9 (4%) | 6 (3%) | 3 (8%) | 0.17 |
Acinic Cell Carcinoma | 3 (1%) | 1 (1%) | 2 (5%) | 0.072 |
Secretory Carcinoma | 2 (1%) | 2 (1%) | 0 (0%) | 1 |
Clear Cell Carcinoma | 3 (1%) | 1 (1%) | 2 (5%) | 0.072 |
Epithelial Myoepithelial Carcinoma | 1 (0%) | 1 (1%) | 0 (0%) | 1 |
Myoepithelial Carcinoma | 1 (0%) | 0 (0%) | 1 (3%) | 0.17 |
Intraductal Carcinoma of Salivary Gland | 1 (0%) | 0 (0%) | 1 (3%) | 0.17 |
Adenocarcinoma NOS | 3 (1%) | 3 (2%) | 0 (0%) | 1 |
Carcinosarcoma | 1 (0%) | 1 (1%) | 0 (0%) | 1 |
*Fisher Exact Test